Sorin Group Announces European Market Release And First Implant Of New-Generation Cardiac Resynchronization Therapy Defibrillator
Dec 2nd 2008Drug InformationCardiovascular
Sorin Group, (MIL:SRN), a global company and a leader in the treatment of cardiovascular diseases, announced today the commercial market release and first implant of its new-generation PARADYM? CRT 8750 cardiac resynchronization therapy defibrillator (CRT-D). Together with the new SITUS? BW 28D left ventricle pacing lead and lead delivery system, PARADYM CRT forms a complete new CRT system for heart failure (HF) patients.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
